RNS Number : 1460V

Omega Diagnostics Group PLC

08 August 2022


("Omega" or the "Company" or the "Group")

Confirmation of Preliminary Results

Investor Presentation

Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Health & Nutrition products, confirms it will issue its preliminary results for the year ended 31 March 2022 on Thursday 18 August 2022.

Investor presentation

Jag Grewal, CEO and Chris Lea, CFO will provide a live presentation relating to the preliminary Results via the Investor Meet Company platform on Thursday 18 August 2022 at 4:30pm BST.

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet Omega Diagnostics Group plc via:


Investors who already follow Omega Diagnostics Group plc on the Investor Meet Company platform will automatically be invited.


  Omega Diagnostics Group PLC                                               www.omegadx.com 
  Jag Grewal, Chief Executive Officer                                       via Walbrook PR 
  Chris Lea, Chief Financial Officer 
  finnCap Ltd                                                            Tel: 020 7220 0500 
  Geoff Nash/Edward Whiley/George Dollemore 
   (Corporate Finance) 
  Alice Lane/ Harriet Ward (ECM) 
  Walbrook PR Limited                            Tel: 020 7933 8780 or omega@walbrookpr.com 
  Lianne Applegarth                                                      Mob: 07584 391 303 
  Sam Allen                                                              Mob: 07502 558 258 

About Omega Diagnostics Group PLC

Omega manufactures and distributes high quality in-vitro diagnostic products for use in hospitals, clinics, laboratories and healthcare practitioners in over 70 countries and is now focused on the health and nutrition sector.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.



(END) Dow Jones Newswires

August 08, 2022 02:00 ET (06:00 GMT)

Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Dec 2022 to Jan 2023 Click Here for more Omega Diagnostics Charts.
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Jan 2022 to Jan 2023 Click Here for more Omega Diagnostics Charts.